论文信息 - Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial - 字舞流文

Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

M. Diamant | M. Kramer | D. V. van Raalte | P. T. ter Wee | J. Joles | A. Danser | M. Smits | T. Hoekstra | M. Muskiet | L. Tonneijck | M. H. Muskiet | D. H. Raalte | A. H. J. Danser | Piet M. ter Wee